| scholarly article | Q13442814 |
| P50 | author | John E. Gerich | Q112187461 |
| P2093 | author name string | P Campbell | |
| G Bolli | |||
| G Perriello | |||
| M Ventura | |||
| P Brunetti | |||
| P De Feo | |||
| S De Cosmo | |||
| P2860 | cites work | Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding | Q70184484 |
| Rdevance of Glucose Counterregulatory Systems to Patients with Diabetes: Critical Roles of Glucagon and Epinephrine | Q70250273 | ||
| Impaired Counterregulation of Hypoglycemia in Insulin-dependent Diabetes Mellitus | Q70290402 | ||
| Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes Mellitus | Q70357501 | ||
| Relation of counterregulatory responses to hypoglycemia in type I diabetics | Q70459758 | ||
| Coated Charcoal Immunoassay of Insulin | Q71162157 | ||
| Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol | Q71372136 | ||
| The effect of growth hormone on glucose metabolism and insulin secretion in man | Q71439834 | ||
| Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man | Q72130225 | ||
| Intrinsic regulation of glucose output by rat liver | Q72366131 | ||
| Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man | Q72436825 | ||
| Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man | Q72487422 | ||
| Hypoglycemic glucose counterregulation in patients with insulin-dependent diabetes mellitus | Q72521649 | ||
| Glucoregulation during insulin and glucagon deficiency: role of catecholamines | Q72533926 | ||
| Microdetermination of long-chain fatty acids in plasma and tissues | Q79216603 | ||
| Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver | Q33799804 | ||
| Amino acid balance across tissues of the forearm in postabsorptive man. Effects of insulin at two dose levels | Q34283565 | ||
| ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE | Q35505149 | ||
| A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma | Q36719102 | ||
| Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus | Q37007413 | ||
| Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man | Q37021401 | ||
| Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function | Q37022441 | ||
| Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. | Q37023863 | ||
| Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon | Q37031053 | ||
| Influence of Continuous Physiologic Hyperinsulinemia on Glucose Kinetics and Counterregulatory Hormones in Normal and Diabetic Humans | Q37038049 | ||
| Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia | Q37039189 | ||
| The Role of the Liver in the Homeostasis of Blood Glucose | Q37253589 | ||
| Glucose-Lactate Inter-Relations in Man | Q39915500 | ||
| The Functional Importance of Sympathetic Nerves to the Liver and Endocrine Pancreas | Q40975127 | ||
| Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones | Q41210907 | ||
| Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man | Q41452468 | ||
| Fructose 2,6-bisphosphate 2 years after its discovery | Q42124382 | ||
| Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization | Q42462924 | ||
| Autoregulation of glucose metabolism in the isolated perfused rat liver | Q44775845 | ||
| Characterization of seven C-peptide antisera | Q46569753 | ||
| Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study | Q48606041 | ||
| Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. | Q51654836 | ||
| Autoregulation by glucose of hepatic glucose balance: permissive effect of insulin. | Q51655553 | ||
| Glucose regulation of hepatic gluconeogenesis. | Q51688039 | ||
| Noninvasive determination of local cerebral metabolic rate of glucose in man. | Q52769111 | ||
| A sensitive and specific fluorimetric method for the determination of noradrenalin and adrenalin in human plasma | Q53005716 | ||
| Tissue effects of glucocorticoids. | Q53889830 | ||
| Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. | Q54524505 | ||
| Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. | Q55062500 | ||
| A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. | Q55062527 | ||
| Dynamics of glucose autoregulation in the isolated, blood-perfused canine liver | Q69797720 | ||
| Dose-response characteristics for effects of insulin on production and utilization of glucose in man | Q70157794 | ||
| Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones | Q70183899 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoglycemia | Q202758 |
| P304 | page(s) | 1623-1631 | |
| P577 | publication date | 1985-05-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Role of hepatic autoregulation in defense against hypoglycemia in humans | |
| P478 | volume | 75 |
| Q34221721 | Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis |
| Q69894185 | Changes in glucagon do not play an essential role in the glucoregulatory responses to mild hyperinsulinemia in dogs |
| Q47203788 | Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. |
| Q43718117 | Contribution of adrenergic mechanisms to glucose counterregulation in humans |
| Q42111754 | Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus |
| Q41276441 | Demonstration of a role for growth hormone in glucose counterregulation |
| Q41178500 | Evidence against important catecholamine compensation for absent glucagon counterregulation |
| Q34258211 | Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration |
| Q48135068 | Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog. |
| Q40883259 | Glucose counterregulation: prevention and correction of hypoglycemia in humans |
| Q34563673 | Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms |
| Q44822011 | Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose |
| Q43510788 | Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction |
| Q35795142 | Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention |
| Q34125384 | Hypoglycemia. Pathophysiology and treatment |
| Q41156510 | Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans |
| Q47150755 | Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs |
| Q58172430 | Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycaemia in normal man |
| Q77779446 | Insulin counterregulatory hormones are ineffective in neonatal hyperinsulinemic hypoglycemia |
| Q51621148 | Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting. |
| Q34360096 | Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs |
| Q40831331 | Intensified insulin therapy. |
| Q33740514 | Physiology of glucose counterregulation to hypoglycemia |
| Q43545395 | Prolonged insulin resistance following insulin-induced hypoglycaemia. |
| Q68950015 | Role of counterregulatory hormones in the regulation of hepatic glucose metabolism |
| Q39631351 | Somogyi and dawn phenomena: mechanisms |
| Q68901127 | Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon |
| Q77441842 | The contribution of glucose to neonatal glucose homeostasis in the lamb |
Search more.